-
XERS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Xeris Biopharma (XERS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 24 | Dec 23 | Jun 23 | Mar 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 63.36 mm | 63.36 mm | 63.36 mm | 63.36 mm | 63.36 mm | 63.36 mm |
Cash burn (monthly) | (no burn) | (no burn) | 4.30 mm | 3.76 mm | 2.77 mm | 2.62 mm |
Cash used (since last report) | n/a | n/a | 17.87 mm | 15.65 mm | 11.51 mm | 10.91 mm |
Cash remaining | n/a | n/a | 45.49 mm | 47.71 mm | 51.85 mm | 52.45 mm |
Runway (months of cash) | n/a | n/a | 10.6 | 12.7 | 18.7 | 20.0 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | Steven Pieper | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 32,059 | 115.73 k | 1,409,761 |
3 Jan 25 | Beth Hecht | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 32,039 | 115.66 k | 1,352,794 |
3 Jan 25 | John Patrick Shannon Jr | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 39,443 | 142.39 k | 2,108,618 |
3 Jan 25 | Kevin McCulloch | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 24,501 | 88.45 k | 1,577,452 |
3 Jan 25 | Kenneth Erland Johnson | Common Stock | Payment of exercise | Dispose F | No | No | 3.61 | 12,401 | 44.77 k | 361,764 |